Shopping Cart 0
Cart Subtotal
USD 0

Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 8000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 12000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Point-of-Care (POC) Analyzers-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Point-of-Care (POC) Analyzers-Medical Devices Pipeline Assessment, 2018" provides an overview of Point-of-Care (POC) Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Point-of-Care (POC) Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Point-of-Care (POC) Analyzers under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Point-of-Care (POC) Analyzers and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Point-of-Care (POC) Analyzers under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 8

2 Introduction 9

2.1 Point-of-Care (POC) Analyzers Overview 9

3 Products under Development 10

3.1 Point-of-Care (POC) Analyzers-Pipeline Products by Stage of Development 10

3.2 Point-of-Care (POC) Analyzers-Pipeline Products by Territory 11

3.3 Point-of-Care (POC) Analyzers-Pipeline Products by Regulatory Path 12

3.4 Point-of-Care (POC) Analyzers-Pipeline Products by Estimated Approval Date 13

3.5 Point-of-Care (POC) Analyzers-Ongoing Clinical Trials 14

4 Point-of-Care (POC) Analyzers-Pipeline Products under Development by Companies 15

4.1 Point-of-Care (POC) Analyzers Companies-Pipeline Products by Stage of Development 15

4.2 Point-of-Care (POC) Analyzers-Pipeline Products by Stage of Development 18

5 Point-of-Care (POC) Analyzers Companies and Product Overview 20

5.1 Acrongenomics Inc. (Inactive) Company Overview 20

5.2 AgPlus Diagnostics LTD Company Overview 21

5.3 Akers Biosciences Inc Company Overview 22

5.4 Akonni Biosystems Inc Company Overview 23

5.5 Alere Inc Company Overview 24

5.6 Analytical Diagnostic Solutions Inc Company Overview 25

5.7 ApoCell Inc Company Overview 26

5.8 Ativa Medical Inc Company Overview 27

5.9 Atonomics A/S Company Overview 28

5.10 Binghamton University Company Overview 29

5.11 Bio-Alternative Medical Devices Ltd Company Overview 30

5.12 BioMedomics Inc Company Overview 31

5.13 bioMerieux SA Company Overview 32

5.14 Biopico Systems Inc Company Overview 33

5.15 Boston University Company Overview 34

5.16 Canon USA Inc Company Overview 35

5.17 CardioGenics Inc Company Overview 36

5.18 Cepheid Company Overview 37

5.19 ChipCare Corp Company Overview 40

5.20 City, University of London Company Overview 41

5.21 Co-Diagnostics HBDC, Inc. Company Overview 42

5.22 Diagnostics For All Inc Company Overview 43

5.23 ExcitePCR Corp Company Overview 44

5.24 Exosome Diagnostics Inc Company Overview 45

5.25 First Light Biosciences Inc Company Overview 46

5.26 Florida International University Company Overview 47

5.27 Fluxergy LLC Company Overview 48

5.28 Giner Inc Company Overview 49

5.29 Indian Institute of Technology Chennai Company Overview 50

5.30 Maxygen-mobile DNA tests Company Overview 51

5.31 mBio Diagnostics Inc Company Overview 52

5.32 McKesson Corp Company Overview 54

5.33 MML Ltd Company Overview 55

5.34 Molecular Warehouse Ltd Company Overview 56

5.35 Nalia Systems Ltd Company Overview 57

5.36 Newcastle University Company Overview 58

5.37 Nikkiso Co Ltd Company Overview 60

5.38 Ohmx Corp Company Overview 61

5.39 OncoGenesis Company Overview 62

5.40 Pacific Nanoscience, Inc. Company Overview 63

5.41 Parallax Health Sciences Inc Company Overview 64

5.42 POC Medical Systems Inc. Company Overview 65

5.43 Quanterix Corp Company Overview 66

5.44 Qvella Corporation Company Overview 67

5.45 Radisens Diagnostics Ltd Company Overview 68

5.46 SenGenix Inc Company Overview 69

5.47 SFC Fluidics LLC Company Overview 70

5.48 StemTek Therapeutics SL Company Overview 71

5.49 Thermal Gradient Inc Company Overview 72

5.50 Trinity Biotech Plc Company Overview 74

5.51 Two Pore Guys Inc Company Overview 75

5.52 University of Calgary Company Overview 76

5.53 University of California Berkeley Company Overview 77

5.54 Wellstat Diagnostics LLC Company Overview 80

6 Point-of-Care (POC) Analyzers- Recent Developments 81

6.1 Jun 28, 2018: McKesson Reaffirms Fiscal 2019 Guidance and Provides Preliminary Guidance for the First Quarter 81

6.2 Jun 25, 2018: PositiveID Subsidiary Chief Science Officer Joins Cambridge Healthtech Institute's 26th Biodetection Technologies: Biothreat and Pathogen Detection 81

6.3 Jun 21, 2018: Abbott Receives FDA Clearance for Afinion HbA1c Dx for Diagnosing Diabetes 81

6.4 Jun 20, 2018: PositiveID CEO Details New Distribution Agreement with Leading Non-Invasive Patient Monitoring Technology Company 82

7 Appendix 114

7.1 Methodology 114

7.2 About GlobalData 117

7.3 Contact Us 117

7.4 Disclaimer 117


List Of Figure

1.2 List of Figures

Figure 1: Point-of-Care (POC) Analyzers-Pipeline Products by Stage of Development 11

Figure 2: Point-of-Care (POC) Analyzers-Pipeline Products by Territory 12

Figure 3: Point-of-Care (POC) Analyzers-Pipeline Products by Regulatory Path 13

Figure 4: Point-of-Care (POC) Analyzers-Pipeline Products by Estimated Approval Date 14

Figure 5: Point-of-Care (POC) Analyzers-Ongoing Clinical Trials 15


List Of Table

1.1 List of Tables

Table 1: Point-of-Care (POC) Analyzers-Pipeline Products by Stage of Development 11

Table 2: Point-of-Care (POC) Analyzers-Pipeline Products by Territory 12

Table 3: Point-of-Care (POC) Analyzers-Pipeline Products by Regulatory Path 13

Table 4: Point-of-Care (POC) Analyzers-Pipeline Products by Estimated Approval Date 14

Table 5: Point-of-Care (POC) Analyzers-Ongoing Clinical Trials 15

Table 6: Point-of-Care (POC) Analyzers Companies-Pipeline Products by Stage of Development 16

Table 7: Point-of-Care (POC) Analyzers-Pipeline Products by Stage of Development 19

Table 8: Acrongenomics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 21

Table 9: BioLED Device-Diabetes Management-Product Status 21

Table 10: BioLED Device-Diabetes Management-Product Description 21

Table 11: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 22

Table 12: AgPlus Diagnostic System-Product Status 22

Table 13: AgPlus Diagnostic System-Product Description 22

Table 14: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Table 15: minDNAnalyzer-Product Status 23

Table 16: minDNAnalyzer-Product Description 23

Table 17: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Table 18: TruDx 2000 Platform-Product Status 24

Table 19: TruDx 2000 Platform-Product Description 24

Table 20: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Table 21: Clondiag HIV Molecular Device-Product Status 25

Table 22: Clondiag HIV Molecular Device-Product Description 25

Table 23: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Table 24: POC Device-Malaria-Product Status 26

Table 25: POC Device-Malaria-Product Description 26

Table 26: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Table 27: ApoStream System-Product Status 27

Table 28: ApoStream System-Product Description 27

Table 29: Ativa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Table 30: Ativa Micro-Lab System-Product Status 28

Table 31: Ativa Micro-Lab System-Product Description 28

Table 32: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 29

Table 33: Atolyzer PoC-Product Status 29

Table 34: Atolyzer PoC-Product Description 29

Table 35: Binghamton University Pipeline Products & Ongoing Clinical Trials Overview 30

Table 36: U-PAC-Product Status 30

Table 37: U-PAC-Product Description 30

Table 38: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Table 39: Magnetic Immunoassay Detection System-Product Status 31

Table 40: Magnetic Immunoassay Detection System-Product Description 31

Table 41: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Table 42: TR-LFIA Diagnostic Platform-Product Status 32

Table 43: TR-LFIA Diagnostic Platform-Product Description 32

Table 44: bioMerieux SA Pipeline Products & Ongoing Clinical Trials Overview 33

Table 45: Magnotech System-Product Status 33

Table 46: Magnotech System-Product Description 33

Table 47: Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 34

Table 48: MONITOR System-Product Status 34

Table 49: MONITOR System-Product Description 34

Table 50: Boston University Pipeline Products & Ongoing Clinical Trials Overview 35

Table 51: Point-Of-Care Device-Allergen-Specific IgE-Product Status 35

Table 52: Point-Of-Care Device-Allergen-Specific IgE-Product Description 35

Table 53: Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Table 54: Automated Diagnostic System-Infectious Disease-Product Status 36

Table 55: Automated Diagnostic System-Infectious Disease-Product Description 36

Table 56: CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Table 57: QL Care Analyzer-Product Status 37

Table 58: QL Care Analyzer-Product Description 37

Table 59: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 38

Table 60: GeneXpert Omni-Product Status 38

Table 61: GeneXpert Omni-Product Description 38

Table 62: Cepheid-Ongoing Clinical Trials Overview 39

Table 63: GeneXpert Omni-Xpert Omni Performance Evaluation for Linkage to Tuberculosis Care: The XPEL TB Trial 40

Table 64: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 41

Table 65: Polyvalent Analyzer (PAx)-Product Status 41

Table 66: Polyvalent Analyzer (PAx)-Product Description 41

Table 67: City, University of London Pipeline Products & Ongoing Clinical Trials Overview 42

Table 68: POC Device-Mood Disorders-Product Status 42

Table 69: POC Device-Mood Disorders-Product Description 42

Table 70: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43

Table 71: LightPCR-Product Status 43

Table 72: LightPCR-Product Description 43

Table 73: Diagnostics For All Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Table 74: Paper-Based Diagnostic Device-Hypertensive Disorders-Product Status 44

Table 75: Paper-Based Diagnostic Device-Hypertensive Disorders-Product Description 44

Table 76: ExcitePCR Corp Pipeline Products & Ongoing Clinical Trials Overview 45

Table 77: FireflyDX-Handheld-Product Status 45

Table 78: FireflyDX-Handheld-Product Description 45

Table 79: Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 46

Table 80: Shahky-Product Status 46

Table 81: Shahky-Product Description 46

Table 82: First Light Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Table 83: MultiPath Analyzer-Product Status 47

Table 84: MultiPath Analyzer-Product Description 47

Table 85: Florida International University Pipeline Products & Ongoing Clinical Trials Overview 48

Table 86: Cortisol Detector-Product Status 48

Table 87: Cortisol Detector-Product Description 48

Table 88: Fluxergy LLC Pipeline Products & Ongoing Clinical Trials Overview 49

Table 89: Fluxergy Analyzer Beta-Product Status 49

Table 90: Fluxergy Analyzer Beta-Product Description 49

Table 91: Giner Inc Pipeline Products & Ongoing Clinical Trials Overview 50

Table 92: Home Monitoring System-Blood Lithium-Product Status 50

Table 93: Home Monitoring System-Blood Lithium-Product Description 50

Table 94: Indian Institute of Technology Chennai Pipeline Products & Ongoing Clinical Trials Overview 51

Table 95: Microfluidic Flow Analyzer-Product Status 51

Table 96: Microfluidic Flow Analyzer-Product Description 51

Table 97: Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview 52

Table 98: Maxygen POC Device-Product Status 52

Table 99: Maxygen POC Device-Product Description 52

Table 100: mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 53

Table 101: MBio Array System-Product Status 53

Table 102: MBio Array System-Product Description 53

Table 103: MBio CD4 System-Product Status 54

Table 104: MBio CD4 System-Product Description 54

Table 105: McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview 55

Table 106: Proventys PDx System-Product Status 55

Table 107: Proventys PDx System-Product Description 55

Table 108: MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 56

Table 109: MIDS Cardiac-Product Status 56

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Acrongenomics Inc. (Inactive), BioLED Device - Diabetes Management; AgPlus Diagnostics LTD, AgPlus Diagnostic System; Akers Biosciences Inc, minDNAnalyzer; Akonni Biosystems Inc, TruDx 2000 Platform; Alere Inc, Clondiag HIV Molecular Device; Analytical Diagnostic Solutions Inc, POC Device - Malaria; ApoCell Inc, ApoStream System; Ativa Medical Inc, Ativa Micro-Lab System; Atonomics A/S, Atolyzer PoC; Binghamton University, U-PAC; Bio-Alternative Medical Devices Ltd, Magnetic Immunoassay Detection System; BioMedomics Inc, TR-LFIA Diagnostic Platform; bioMerieux SA, Magnotech System; Biopico Systems Inc, MONITOR System; Boston University, Point-Of-Care Device - Allergen-Specific IgE; Canon USA Inc, Automated Diagnostic System - Infectious Disease; CardioGenics Inc, QL Care Analyzer; Cepheid, GeneXpert Omni; ChipCare Corp, Polyvalent Analyzer (PAx); City, University of London, POC Device - Mood Disorders; Co-Diagnostics HBDC, Inc., LightPCR; Diagnostics For All Inc, Paper-Based Diagnostic Device - Hypertensive Disorders; ExcitePCR Corp, FireflyDX-Handheld; Exosome Diagnostics Inc, Shahky; First Light Biosciences Inc, MultiPath Analyzer; Florida International University, Cortisol Detector; Fluxergy LLC, Fluxergy Analyzer Beta; Giner Inc, Home Monitoring System - Blood Lithium; Indian Institute of Technology Chennai, Microfluidic Flow Analyzer; Maxygen-mobile DNA tests, Maxygen POC Device; mBio Diagnostics Inc, MBio Array System; mBio Diagnostics Inc, MBio CD4 System; McKesson Corp, Proventys PDx System; MML Ltd, MIDS Cardiac; Molecular Warehouse Ltd, Portable Biosensor Device; Nalia Systems Ltd, NALIA Single-Patient Point-Of-Care Device; Newcastle University, SmartHEALTH POC System - Cervical Cancer; Newcastle University, SmartHEALTH POC System - Colorectal Cancer; Nikkiso Co Ltd, Micro Fluidic Device; Ohmx Corp, Handheld Clinical Analyzer; OncoGenesis, Genesis Point-Of-Care Diagnostic System; Pacific Nanoscience, Inc., Nanomonitor; Parallax Health Sciences Inc, SPARKS Mobile; POC Medical Systems Inc., Pandora CDx Point-of-Care System; Quanterix Corp, Simoa 5.0; Qvella Corporation, FAST (Field Activated Sample Treatment) ID System; Radisens Diagnostics Ltd, Radisens Instrument; SenGenix Inc, SenGenix Strips And Reader System; SFC Fluidics LLC, BioSmart; StemTek Therapeutics SL, POC System - Cancer; Thermal Gradient Inc, FlashDirect-HC; Thermal Gradient Inc, FlashDirect-LC; Trinity Biotech Plc, Meritas Point of Care Analyzer; Two Pore Guys Inc, Handheld Nanopore Based Device - Cancer; University of Calgary, Diagnostic Tool - Brain Injury; University of California Berkeley, Microfluidic Blotting Device; University of California Berkeley, Mobile Molecular Diagnostics System; University of California Berkeley, Multi-dimensional Microfluidic Device; University of California Berkeley, Point-Of-Care Microfluidic Device - Acute Promyelocytic Leukemia; Wellstat Diagnostics LLC, Electrochemiluminescent Based RNA Detection Platform


Companies

Acrongenomics Inc.

AgPlus Diagnostics LTD

Akers Biosciences Inc

Akonni Biosystems Inc

Alere Inc

Analytical Diagnostic Solutions Inc

ApoCell Inc

Ativa Medical Inc

Atonomics A/S

Binghamton University

Bio-Alternative Medical Devices Ltd

BioMedomics Inc

bioMerieux SA

Biopico Systems Inc

Boston University

Canon USA Inc

CardioGenics Inc

Cepheid

ChipCare Corp

City, University of London

Co-Diagnostics HBDC, Inc.

Diagnostics For All Inc

ExcitePCR Corp

Exosome Diagnostics Inc

First Light Biosciences Inc

Florida International University

Fluxergy LLC

Giner Inc

Indian Institute of Technology Chennai

Maxygen-mobile DNA tests

mBio Diagnostics Inc

McKesson Corp

MML Ltd

Molecular Warehouse Ltd

Nalia Systems Ltd

Newcastle University

Nikkiso Co Ltd

Ohmx Corp

OncoGenesis

Pacific Nanoscience, Inc.

Parallax Health Sciences Inc

POC Medical Systems Inc.

Quanterix Corp

Qvella Corporation

Radisens Diagnostics Ltd

SenGenix Inc

SFC Fluidics LLC

StemTek Therapeutics SL

Thermal Gradient Inc

Trinity Biotech Plc

Two Pore Guys Inc

University of Calgary

University of California Berkeley

Wellstat Diagnostics LLC